BlackRock Investment Management, LLC - ONCOCYTE CORP ownership

ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 34 filers reported holding ONCOCYTE CORP in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
BlackRock Investment Management, LLC ownership history of ONCOCYTE CORP
ValueSharesWeighting
Q4 2016$5,000
+25.0%
7150.0%0.00%
Q3 2016$4,000
+100.0%
715
+54.8%
0.00%
Q2 2016$2,000
-95.5%
462
-95.1%
0.00%
Q1 2016$44,0009,5220.00%
Other shareholders
ONCOCYTE CORP shareholders Q1 2017
NameSharesValueWeighting ↓
BROADWOOD CAPITAL INC 3,056,680$15,895,0002.92%
IHT Wealth Management, LLC 200$386,0000.19%
Family Management Corp 22,570$117,0000.08%
Artal Group S.A. 150,000$780,0000.01%
Destination Wealth Management 29,656$154,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 145,000$754,0000.01%
Advisor Group, Inc. 102$1,0000.00%
FIFTH THIRD BANCORP 210$1,0000.00%
HUNTINGTON NATIONAL BANK 10$00.00%
AMERICAN INTERNATIONAL GROUP, INC. 2,233$12,0000.00%
View complete list of ONCOCYTE CORP shareholders